, Volume 201, Issue 3, pp 339–350 | Cite as

18-Methoxycoronaridine: a potential new treatment for obesity in rats?

  • Olga D. Taraschenko
  • Heather Y. Rubbinaccio
  • Isabelle M. Maisonneuve
  • Stanley D. Glick
Original Investigation



Excessive eating often leads to obesity. Although a variety of neurotransmitters and brain regions are involved in modulating food intake, a role of accumbal dopamine is thought to be critical for several aspects of this behavior. Since 18-methoxycoronaridine (18-MC), a selective antagonist of α3β4 nicotinic receptors, was previously shown to alter dopamine release in the nucleus accumbens in response to chronic injections of cocaine and morphine, this drug could be a promising therapy for abnormal eating behavior.


Assess the effect of 18-MC on the consumption of sucrose (15%) vs. water in a self-administration paradigm and on the intake of freely available palatable fluids (i.e., 5% sucrose, 0.1% saccharin, and 0.6% saline solutions) as well as on water intake. Determine whether repeated administration of 18-MC (20 mg/kg i.p.) affects weight gain, food intake, and fat deposition in rats drinking 30% sucrose solution.


Acute administration of 18-MC (10–40 mg/kg i.p.) reduced operant responding for sucrose and decreased ad libitum ingestion of sucrose, saccharin, and saline. The highest dose of 18-MC also reduced consumption of water when palatable fluids were not available. In rats having unlimited access to sucrose (30%), chronic treatment with 18-MC (20 mg/kg i.p.) prevented sucrose-induced increases in body weight, decreased fat deposition, and reduced consumption of sucrose while not altering food intake.


These data suggest that antagonism of α3β4 nicotinic receptors may be involved in the regulation of intake of palatable substances regardless of its caloric value and may participate in maintaining obesity.


Palatable fluids Feeding behavior Nicotinic receptors Obesity 



This study was supported by NIDA grant DA016283. The authors would like to thank Michael Bryda for the technical assistance.


  1. Alkondon M, Albuquerque EX (2005) Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion. J Pharmacol Exp Ther 313:740–750PubMedCrossRefGoogle Scholar
  2. Avena NM, Hoebel BG (2003) A diet promoting sugar dependency causes behavioral cross-sensitization to a low dose of amphetamine. Neuroscience 122:17–20PubMedCrossRefGoogle Scholar
  3. Avena NM, Rada P, Hoebel BG (2007) Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32:20–39PubMedCrossRefGoogle Scholar
  4. Berridge KC (1996) Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 20:1–25PubMedCrossRefGoogle Scholar
  5. Berthoud HR (2002) Multiple neural systems controlling food intake and body weight. Neurosci Biobehav Rev 26:393–428PubMedCrossRefGoogle Scholar
  6. Blaha V, Yang ZJ, Meguid M, Chai JK, Zadak Z (1998) Systemic nicotine administration suppresses food intake via reduced meal sizes in both male and female rats. Acta Medica (Hradec Kralove) 41:167–173Google Scholar
  7. Bock BC, Kanarek RB, Aprille JR (1995) Mineral content of the diet alters sucrose-induced obesity in rats. Physiol Behav 57:659–668PubMedCrossRefGoogle Scholar
  8. Bray GA (2000) Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int J Obes Relat Metab Disord 24(Suppl 2):S8–S17PubMedGoogle Scholar
  9. Bray GA, Greenway FL (2007) Pharmacological treatment of the overweight patient. Pharmacol Rev 59:151–184PubMedCrossRefGoogle Scholar
  10. Bray GA, York B, DeLany J (1992) A survey of the opinions of obesity experts on the causes and treatment of obesity. Am J Clin Nutr 55:151S–154SPubMedGoogle Scholar
  11. Bray GA, Nielsen SJ, Popkin BM (2004) Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79:537–543PubMedGoogle Scholar
  12. Carlson JN, Glick SD (1989) Cerebral lateralization as a source of interindividual differences in behavior. Experientia 45:788–798PubMedCrossRefGoogle Scholar
  13. Colantuoni C, Rada P, McCarthy J, Patten C, Avena NM, Chadeayne A, Hoebel BG (2002) Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 10:478–488PubMedCrossRefGoogle Scholar
  14. Dess NK (2000) Responses to basic taste qualities in rats selectively bred for high versus low saccharin intake. Physiol Behav 69:247–257PubMedCrossRefGoogle Scholar
  15. Dhar S, Nagy F, McIntosh JM, Sapru HN (2000) Receptor subtypes mediating depressor responses to microinjections of nicotine into medial NTS of the rat. Am J Physiol Regul Integr Comp Physiol 279:R132–R140PubMedGoogle Scholar
  16. Di Angelantonio S, Matteoni C, Fabbretti E, Nistri A (2003) Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells. Eur J Neurosci 17:2313–2322PubMedCrossRefGoogle Scholar
  17. Di Chiara G (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375:13–30PubMedCrossRefGoogle Scholar
  18. Fregly MJ, Rowland NE (1992) Comparison of preference thresholds for NaCl solution in rats of the Sprague–Dawley and Long–Evans strains. Physiol Behav 51:915–918PubMedCrossRefGoogle Scholar
  19. Giniatullin R, Nistri A, Yakel JL (2005) Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci 28:371–378PubMedCrossRefGoogle Scholar
  20. Glick SD, Hinds PA (1985) Differences in amphetamine and morphine sensitivity in lateralized and non-lateralized rats: locomotor activity and drug self-administration. Eur J Pharmacol 118:239–244PubMedCrossRefGoogle Scholar
  21. Glick SD, Kuehne ME, Maisonneuve IM, Bandarage UK, Molinari HH (1996) 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res 719:29–35PubMedCrossRefGoogle Scholar
  22. Glick SD, Maisonneuve IM, Visker KE, Fritz KA, Bandarage UK, Kuehne ME (1998) 18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats. Psychopharmacology (Berl) 139:274–280CrossRefGoogle Scholar
  23. Glick SD, Maisonneuve IM, Kuehne ME, Bandarage UK (1999) (±)18-Metoxycoronaridine: a novel iboga alkaloid congener having potential anti-addictive efficacy. CNS Drug Rev 5(1):27–42 (Neva Press, Branford, CT)Google Scholar
  24. Glick SD, Maisonneuve IM, Dickinson HA (2000) 18-MC reduces methamphetamine and nicotine self-administration in rats. NeuroReport 11:2013–2015PubMedCrossRefGoogle Scholar
  25. Greenhalgh CE, Smith JW, Clifton PG (2008) WO03/062224 is an in vivo selective agonist at nicotinic beta4 receptors. Pharmacol Biochem Behav (in press)Google Scholar
  26. Guide for the Care and Use of Laboratory Animals (1996). Institute of Laboratory Animal Resources Commission for Life Sciences, National Research Council. National Academy Press, Washington, D.C.Google Scholar
  27. Hajnal A, Norgren R (2001) Accumbens dopamine mechanisms in sucrose intake. Brain Res 904:76–84PubMedCrossRefGoogle Scholar
  28. Hausmann M (1933) The behavior of albino rats in choosing foods: II. Differentiaion between sugar and saccharin. J Comp Psychol 15:419–428CrossRefGoogle Scholar
  29. Hayward MD, Schaich-Borg A, Pintar JE, Low MJ (2006) Differential involvement of endogenous opioids in sucrose consumption and food reinforcement. Pharmacol Biochem Behav 85:601–611PubMedCrossRefGoogle Scholar
  30. Jerlhag E, Egecioglu E, Dickson SL, Svensson L, Engel JA (2008) Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. Eur Neuropsychopharmacol 18:508–518PubMedCrossRefGoogle Scholar
  31. Jias LM, Ellison G (1990) Chronic nicotine induces a specific appetite for sucrose in rats. Pharmacol Biochem Behav 35:489–491PubMedCrossRefGoogle Scholar
  32. Jo YH, Talmage DA, Role LW (2002) Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 53:618–632PubMedCrossRefGoogle Scholar
  33. Kirkham TC, Williams CM (2001) Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl) 153:267–270CrossRefGoogle Scholar
  34. Maisonneuve IM, Glick SD (1999) Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine. Eur J Pharmacol 383:15–21PubMedCrossRefGoogle Scholar
  35. Maisonneuve IM, Glick SD (2003) Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol Biochem Behav 75:607–618PubMedCrossRefGoogle Scholar
  36. Mark GP, Blander DS, Hoebel BG (1991) A conditioned stimulus decreases extracellular dopamine in the nucleus accumbens after the development of a learned taste aversion. Brain Res 551:308–310PubMedCrossRefGoogle Scholar
  37. McHugh PR (1979) Aspects of the control of feeding: application of quantitation in psychobiology. Johns Hopkins Med J 144:147–155PubMedGoogle Scholar
  38. Nguyen HN, Rasmussen BA, Perry DC (2003) Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther 307:1090–1097PubMedCrossRefGoogle Scholar
  39. Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW (2004) Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Eur J Pharmacol 492:159–167PubMedCrossRefGoogle Scholar
  40. Rada P, Avena NM, Hoebel BG (2005) Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 134:737–744PubMedCrossRefGoogle Scholar
  41. Rho B, Glick SD (1998) Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats. NeuroReport 9:1283–1285PubMedCrossRefGoogle Scholar
  42. Roussin AT, Victor JD, Chen JY, Di Lorenzo PM (2007) Variability in responses and temporal coding of tastants of similar quality in the nucleus of the solitary tract of the rat. J Neurophysiol 99:644–655PubMedCrossRefGoogle Scholar
  43. Sato K, Endo S, Tomita H (2002) Sensitivity of three loci on the tongue and soft palate to four basic tastes in smokers and non-smokers. Acta Otolaryngol Suppl 546:74–82PubMedCrossRefGoogle Scholar
  44. Sclafani A (2006) Sucrose motivation in sweet “sensitive” (C57BL/6J) and “subsensitive” (129P3/J) mice measured by progressive ratio licking. Physiol Behav 87:734–744PubMedCrossRefGoogle Scholar
  45. Sclafani A, Ackroff K (2003) Reinforcement value of sucrose measured by progressive ratio operant licking in the rat. Physiol Behav 79:663–670PubMedCrossRefGoogle Scholar
  46. Speakman J, Hambly C, Mitchell S, Krol E (2007) Animal models of obesity. Obes Rev 8(Suppl 1):55–61PubMedCrossRefGoogle Scholar
  47. Stefurak TL, van der KD (1992) Saccharin’s rewarding, conditioned reinforcing, and memory-improving properties: mediation by isomorphic or independent processes? Behav Neurosci 106:125–139PubMedCrossRefGoogle Scholar
  48. Stewart RB, Russell RN, Lumeng L, Li TK, Murphy JM (1994) Consumption of sweet, salty, sour, and bitter solutions by selectively bred alcohol-preferring and alcohol-nonpreferring lines of rats. Alcohol Clin Exp Res 18:375–381PubMedCrossRefGoogle Scholar
  49. Tomassini S, Cuoghi V, Catalani E, Casini G, Bigiani A (2007) Long-term effects of nicotine on rat fungiform taste buds. Neuroscience 147:803–810PubMedCrossRefGoogle Scholar
  50. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357:354–357PubMedCrossRefGoogle Scholar
  51. Warwick ZS, Weingarten HP (1996) Flavor-postingestive consequence associations incorporate the behaviorally opposing effects of positive reinforcement and anticipated satiety: implications for interpreting two-bottle tests. Physiol Behav 60:711–715PubMedGoogle Scholar
  52. Wong GT, Gannon KS, Margolskee RF (1996) Transduction of bitter and sweet taste by gustducin. Nature 381:796–800PubMedCrossRefGoogle Scholar
  53. Yach D, Stuckler D, Brownell KD (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12:62–66PubMedCrossRefGoogle Scholar
  54. Zhang W, Ramamoorthy Y, Tyndale RF, Glick SD, Maisonneuve IM, Kuehne ME, Sellers EM (2002) Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19. Drug Metab Dispos 30:663–669PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Olga D. Taraschenko
    • 1
  • Heather Y. Rubbinaccio
    • 1
  • Isabelle M. Maisonneuve
    • 1
  • Stanley D. Glick
    • 1
  1. 1.Center for Neuropharmacology and Neuroscience MC-136Albany Medical CollegeAlbanyUSA

Personalised recommendations